, Volume 37, Issue 2, pp 358–364 | Cite as

Protective Effect of p-Cymene on Lipopolysaccharide-Induced Acute Lung Injury in Mice

  • Lvyi Chen
  • Lei Zhao
  • Chunfeng ZhangEmail author
  • Zhou LanEmail author


In the previous study, the anti-inflammatory effect of p-cymene had been found. In this study, we investigated anti-inflammatory effects of p-cymene on acute lung injury using lipopolysaccharide (LPS)-induced acute lung injury (ALI) mouse model. The cell counting in the bronchoalveolar lavage fluid (BALF) was measured. The animal lung edema degree was evaluated by wet/dry weight (W/D) ratio. The superoxidase dismutase (SOD) activity and myeloperoxidase (MPO) activity was assayed by SOD and MPO kits, respectively. The levels of inflammatory mediators including tumor necrosis factor alpha (TNF-α), IL-1β, and IL-6 were assayed by enzyme-linked immunosorbent assay method. The pathological changes of the lung tissues were observed by hematoxylin and eosin staining. The inflammatory signal pathway-related protein levels of NF-κB were measured using Western blotting. The data showed that treatment with the p-cymene markedly attenuated inflammatory cell numbers in the BALF, decreased NF-κB protein level in the lungs, improved SOD activity, and inhibited MPO activity. Histological studies demonstrated that p-cymene substantially inhibited LPS-induced neutrophils in the lung tissue compared with the model group. The results indicated that p-cymene had a protective effect on LPS-induced ALI in mice.


p-cymene inflammation LPS-induced acute lung injury NF-κB 



The project was supported by Chinese National Project of “Twelfth Five-Year” Plan for Science & Technology Support (2012BAI27B06), the Special Fund for Basic Scientific Research of Central Colleges, South-Central University for Nationalities (no. CZY13016), the Natural Science Foundation of China (81303284) and the Planning of Deeply Participating into the Enterprises for Young Teachers (XD2012060).


  1. 1.
    Rubenfeld, G.D. 2003. Epidemiology of acute lung injury. Critical Care Medicine 31: S276–S284.PubMedCrossRefGoogle Scholar
  2. 2.
    Zhang, X.M., K.J. Song, H.Z. Xiong, H.Y. Li, X. Chu, and X.M. Deng. 2009. Protective effect of florfenicol on acute lung injury induced by lipopolysaccharide in mice. International Immunopharmacology 9: 1525–1529.PubMedCrossRefGoogle Scholar
  3. 3.
    Matthay, M.A., G.A. Zimmerman, C. Esmon, J. Bhattacharya, B. Coller, C.M. Doerschuk, et al. 2003. Future research directions in acute lung injury summary of a national heart lung and blood institute working group. American Journal of Respiratory and Critical Care Medicine 167: 1027–1035.PubMedCrossRefGoogle Scholar
  4. 4.
    Chen, Z., X. Zhang, X. Chu, X. Zhang, K. Song, Y. Jiang, L. Yu, and X. Deng. 2010. Preventive effects of valnemulin on lipopolysaccharide-induced acute lung injury in mice. Inflammation 33: 306–314.PubMedCrossRefGoogle Scholar
  5. 5.
    Hewett, J.A., and R.A. Roth. 1993. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacological Reviews 45: 382–411.PubMedGoogle Scholar
  6. 6.
    Kubes, P., and D.M. McCafferty. 2000. Nitric oxide and intestinal inflammation. American Journal of Medicine 109: 150–158.PubMedCrossRefGoogle Scholar
  7. 7.
    Watson, W.H., Y. Zhao, and R.K. Chawla. 1999. S-adenosylmethionine attenuates the lipopolysaccharide-induced expression of the gene for tumour necrosis factor alpha. Biochemical Journal 342: 21–25.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Itoh, T., H. Obata, S. Murakami, K. Hamada, K. Kangawa, H. Kimura, and N. Nagaya. 2007. Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. American Journal of Physiology 293: L446–L452.PubMedGoogle Scholar
  9. 9.
    Riedemann, N.C., M.E. Murphy, H.S. Murphy, and P.A. Ward. 2003. Regulatory effects of iNOS on acute lung inflammatory responses in mice. American Journal of Pathology 163: 2319–2328.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Chojkier, M., and D.A. Brenner. 1988. Therapeutic strategies for hepatic fibrosis. Hepatology 8: 176–182.PubMedCrossRefGoogle Scholar
  11. 11.
    Wu, J., and A. Danielsson. 1994. Inhibition of hepatic fibrogenesis: A review of pharmacologic candidates. Scandinavian Journal of Gastroenterology 29: 385–391.PubMedCrossRefGoogle Scholar
  12. 12.
    Cavalli, J.F., F. Tomi, A.F. Bernardini, and J. Casanova. 2004. Combined analysis of the essential oil of Chenopodium ambrosioides by GC, GC-MS and 13C-NMR spectroscopy: Quantitative determination of ascaridole, a heat- sensitive compound. Phytochemical Analysis 15: 275–279.PubMedCrossRefGoogle Scholar
  13. 13.
    Khokra, S.L., O. Prakash, S. Jain, K.R. Aneja, and Y. Dhingra. 2008. Essential oil composition and antibacterial studies of Vitex negundo Linn. extracts. Indian Journal of Pharmaceutical Sciences 70: 522–526.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Alma, M.H., A. Mavi, A. Yildirim, M. Digrak, and T. Hirata. 2003. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biological and Pharmaceutical Bulletin 26: 1725–1729.PubMedCrossRefGoogle Scholar
  15. 15.
    Zhong, Weiting, Gefu Chi, and Lanxiang Jiang. 2013. p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation. Inflammation 26(3): 529–537.CrossRefGoogle Scholar
  16. 16.
    Yunhe, Fu., Liu Bo, Feng Xiaosheng, et al. 2012. The effect of magnolol on the toll-like receptor 4/nuclear factor kappa B signaling pathway in lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 689: 255–261.PubMedCrossRefGoogle Scholar
  17. 17.
    Rubenfeld, G.D. 2003. Epidemiology of acute lung injury. Critical Care Medicine 31: 276–284.CrossRefGoogle Scholar
  18. 18.
    Nanashima, N., M. Akita, T. Yamada, T. Shimizu, H. Nakano, Y. Fan, et al. 2008. The hairless phenotype of the Hirosaki hairless rat is due to the deletion of an 80-kb genomic DNA containing five basic keratin genes. Journal of Biological Chemistry 283: 16868–16875.PubMedCrossRefGoogle Scholar
  19. 19.
    Parsey, M.V., R. Tuder, and E. Abraham. 1998. Neutrophils are major contributors to intraparenchymal lung IL-1β expression after hemorrhage and endotoxemia. The Journal of Immunology 160: 1007–1101.PubMedGoogle Scholar
  20. 20.
    Shenkar, R., and E. Abraham. 1999. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: Roles of reactive oxygen intermediates, NF-κB, and cyclic AMP response element binding protein. The Journal of Immunology 163: 954–962.PubMedGoogle Scholar
  21. 21.
    Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. The Journal of Investigative Dermatology 78: 206–209.PubMedCrossRefGoogle Scholar
  22. 22.
    Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. Journal of Pathology 202: 145–156.PubMedCrossRefGoogle Scholar
  23. 23.
    Cribbs, S.K., M.A. Matthay, and G.S. Martin. 2010. Stem cells in sepsis and acute lung injury. Critical Care Medicine 38: 2379–2385.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Goodman, R.B., J. Pugin, J.S. Lee, and M.A. Matthay. 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine and Growth Factor Reviews 14: 523–535.PubMedCrossRefGoogle Scholar
  25. 25.
    Giebelen, I.A., D.J. van Westerloo, G.J. LaRosa, A.F. de Vos, and T. van der Poll. 2007. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28: 700–703.PubMedGoogle Scholar
  26. 26.
    Abraham, E. 2000. NF-kappaB activation. Critical Care Medicine 28: 100–104.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.College of PharmacySouth-Central University for NationalitiesWuhanPeople’s Republic of China
  2. 2.Key Laboratory of Chemistry and Quality for Traditional Chinese Medicines of the College of Gansu ProvinceGansu College of Traditional Chinese MedicineLanzhouPeople’s Republic of China
  3. 3.Key Laboratory of Modern Chinese Medicines, China Pharmaceutical UniversityMinistry of EducationNanjingPeople’s Republic of China
  4. 4.School of PharmacyHubei University of Chinese MedicineWuhanPeople’s Republic of China

Personalised recommendations